InvestorsHub Logo
Followers 29
Posts 1685
Boards Moderated 0
Alias Born 02/26/2015

Re: Justaddmuscle post# 560

Wednesday, 04/22/2015 10:08:20 PM

Wednesday, April 22, 2015 10:08:20 PM

Post# of 2839
BL-1040 for prevention of pathological cardiac remodeling following a myocardial infarction, which has been out-licensed to Bellerophon BCM (f/k/a Ikaria) and is in the midst of a pivotal CE-Mark registration trial scheduled for completion in mid-2015


dont forget aboit this..should hear news end on this month or 1st of may...was waiting the 6month period for patient side effects been since december...december-may is 6 months in my book..thats REVs people
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLRX News